BioCentury | Dec 3, 2020
Finance

Dec. 2 Quick Takes: venture rounds for Genesis, Biosight; plus: Frontier-AbbVie, Exelixis-Iconic, UCB-Specifica and Click

...A round led by Rock Springs Capital; T. Rowe Price Associates, Andreessen Horowitz, Menlo Ventures, Radical Ventures...
BioCentury | Jan 9, 2020
Financial News

Aspect to engineer therapeutic tissues with $20M series A

...a $20 million series A round to develop the engineered tissues as therapeutics. New investor Radical Ventures...
Items per page:
1 - 2 of 2
BioCentury | Dec 3, 2020
Finance

Dec. 2 Quick Takes: venture rounds for Genesis, Biosight; plus: Frontier-AbbVie, Exelixis-Iconic, UCB-Specifica and Click

...A round led by Rock Springs Capital; T. Rowe Price Associates, Andreessen Horowitz, Menlo Ventures, Radical Ventures...
BioCentury | Jan 9, 2020
Financial News

Aspect to engineer therapeutic tissues with $20M series A

...a $20 million series A round to develop the engineered tissues as therapeutics. New investor Radical Ventures...
Items per page:
1 - 2 of 2